AIDiagnosticKit.com

by Reiwaing
977 views

Let’s overcome the corona virus.

AIDiagnosticKit.com is for sale!

– AI Diagnostic Kit / Coronavirus / COVID-19 –

Selling on DAN.com

 

 

AI diagnostics have the potential to improve the delivery and effectiveness of health care. Many are a triumph for science, representing years of improvements in computing power and the neural networks that underlie deep learning. In this form of AI, computers process hundreds of thousands of labelled disease images, until they can classify the images unaided. In reports, researchers conclude that an algorithm is successful if it can identify a particular condition from such images as effectively as can pathologists and radiologists.

On Monday, February 3, 2020, CDC submitted an Emergency Use Authorization (EUA) package to the U.S. Food and Drug Administration (FDA) in order to expedite FDA permitted use of the CDC diagnostic panel in the United States. The EUA process enables FDA to consider and authorize the use of unapproved, but potentially life-saving medical or diagnostic products during a public health emergency. The U.S. Secretary of Health and Human Services declared the SARS-CoV-2 virus a U.S. public health emergency on Friday, January 31, 2020. FDA issued the EUA on February 4, 2020. IRR began distribution of the test kits to states, but shortly thereafter performance issues were identified related to a problem in the manufacturing of one of the reagents which led to laboratories not being able to verify the test performance. CDC is remanufacturing the reagents with more robust quality control measures. New tests will be distributed once this issue has been addressed. CDC continues to perform initial and confirmatory testing.

Serology Test for COVID-19
CDC is working to develop a new laboratory test to assist with efforts to determine how much of the U.S. population has been exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19.

The serology test will look for the presence of antibodies, which are specific proteins made in response to infections. Antibodies can be found in the blood and in other tissues of those who are tested after infection. The antibodies detected by this test indicate that a person had an immune response to SARS-CoV-2, whether symptoms developed from infection or the infection was asymptomatic. Antibody test results are important in detecting infections with few or no symptoms.

Initial work to develop a serology test for SARS-CoV-2 is underway at CDC. In order to develop the test, CDC needs blood samples from people who had COVID-19 at least 21 days after their symptoms first started. Researchers are currently working to develop the basic parameters for the test, which will be refined as more samples become available. Once the test is developed, CDC will need additional samples to evaluate whether the test works as intended.

 

 

 

Start trading your perfect domain right away.

Start selling on GoDaddy, SEDO, DAN

Reiwaing

 

 

You may also like